Clinical trials: Hammer Toe Syndrome
Hammertoe, Hammer Toe Syndrome
Mg Alloy DrillPins in Hammertoe Deformity Correction
This is a prospective, single-arm clinical feasibility study evaluating the safe application of a novel lean absorbable magnesium-zinc-calcium alloy (ZX00) drill pin (RemeOs™ DrillPin) for the surgical correction of hammertoe…
- Trial name
- NCT07121790
- Testing
- Implant Mg-based RemeOs™ drillpins
- Volunteers
- 20 people
- Sponsor
- Bioretec Ltd.
Hallux Valgus
Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery
Study designed to evaluate the efficacy and safety of Intranasal (IN) Morphine Nasal Spray (MNS075) 3.75 mg, 7.5 mg, 15 mg, and 30 mg, intravenous (IV) morphine 7.5 mg, or IN placebo in patients with moderate to severe…
- Trial name
- NCT00388011
- Testing
- Intranasal Morphine (MNS075) 3.75 mg, Intravenous Morphine 7.5 mg, Intranasal morphine (MNS075) 7.5 mg
- Volunteers
- 187 people
- Sponsor
- Javelin Pharmaceuticals
Hammer Toe, Claw Toe
Short Term Follow-up of Patient Implanted With the Proximal Interphalangeal Implant
Hammertoe and ClawToe are ones of the most common foot deformities. The second toe is the most frequently affected, but the other small toes may also be involved. When nonoperative treatment fails, surgery often is recommended.
- Conditions
- Hammer Toe, Claw Toe, Shortening 2nd Toe, Revision of Arthrodesis or Arthroplasty Failure
- Trial name
- NCT01285011
- Where
- 5 sites in Belgium, France and 1 more
- Volunteers
- 156 people
- Sponsor
- Integra LifeSciences Services